Ignite Creation Date:
2025-12-24 @ 5:32 PM
Ignite Modification Date:
2026-01-18 @ 9:00 AM
Study NCT ID:
NCT05162768
Status:
COMPLETED
Last Update Posted:
2025-10-24
First Post:
2021-12-08
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Study to Evaluate Efficacy and Safety of Elamipretide in Subjects With Primary Mitochondrial Disease From Nuclear DNA Mutations (nPMD)
Sponsor:
Stealth BioTherapeutics Inc.
Organization:
Conditions & Keywords Data
Conditions:
Conditions
| Condition Brief | Condition Text | View |
|---|---|---|
| None | Mitochondrial Myopathies | View |
| None | Mitochondrial Pathology | View |
| None | Mitochondrial DNA Mutation | View |
| None | Mitochondrial Diseases | View |
| None | Mitochondrial DNA Deletion | View |
| None | Mitochondrial DNA Depletion | View |
| None | Mitochondrial Metabolism Defect | View |
| None | Mitochondrial Complex I Deficiency | View |
Keywords:
Keywords
| Keyword Brief | Keyword Text | View |
|---|---|---|
| None | primary mitochondrial myopathy (PMM) | View |
| None | nuclear DNA mutations n(PMD) | View |
| None | exercise intolerance | View |
| None | muscle weakness | View |
| None | mitochondrial dysfunction | View |
| None | POLG | View |
| None | TWINKLE | View |
| None | progressive external ophthalmoplegia | View |
| None | Elamipretide | View |
| None | mitochondrial replisome | View |
| None | replisome related mutations | View |
| None | MTP-131 | View |
| None | primary mitochondrial disease (PMD) | View |